TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 33 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,038,000 | +132.2% | 286,918 | +28.2% | 0.00% | – |
Q2 2021 | $2,170,000 | +9.3% | 223,801 | +21.1% | 0.00% | – |
Q1 2021 | $1,986,000 | -69.3% | 184,856 | -58.0% | 0.00% | – |
Q4 2020 | $6,469,000 | +244.6% | 439,812 | +232.9% | 0.00% | – |
Q3 2020 | $1,877,000 | +75.1% | 132,100 | -0.3% | 0.00% | – |
Q2 2020 | $1,072,000 | +50.8% | 132,500 | -24.7% | 0.00% | – |
Q1 2020 | $711,000 | +35450.0% | 176,042 | +8702.1% | 0.00% | – |
Q4 2019 | $2,000 | – | 2,000 | +700.0% | 0.00% | – |
Q2 2019 | $0 | – | 250 | +150.0% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 100 | -83.3% | 0.00% | – |
Q4 2018 | $1,000 | -80.0% | 600 | -21.4% | 0.00% | – |
Q2 2018 | $5,000 | +150.0% | 763 | +90.8% | 0.00% | – |
Q3 2017 | $2,000 | -71.4% | 400 | -63.6% | 0.00% | – |
Q1 2017 | $7,000 | -92.1% | 1,100 | -93.0% | 0.00% | – |
Q4 2016 | $89,000 | +1383.3% | 15,800 | +3850.0% | 0.00% | – |
Q3 2016 | $6,000 | – | 400 | +19900.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 2 | -99.8% | 0.00% | – |
Q1 2016 | $7,000 | +75.0% | 800 | +179.7% | 0.00% | – |
Q4 2015 | $4,000 | 0.0% | 286 | -6.8% | 0.00% | – |
Q3 2015 | $4,000 | – | 307 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 206,800 | $36,314,000 | 8.27% |
Fairmount Funds Management LLC | 886,281 | $15,563,000 | 5.66% |
FRAZIER MANAGEMENT LLC | 3,123,107 | $54,984,000 | 4.40% |
ACT CAPITAL MANAGEMENT, LLC | 466,000 | $8,183,000 | 4.24% |
RAMIUS ADVISORS LLC | 338,042 | $5,936,000 | 3.54% |
Western Standard LLC | 265,355 | $4,660,000 | 2.65% |
HAVENS ADVISORS LLC | 109,000 | $1,914,000 | 2.30% |
Crabel Capital Management, LLC | 423,490 | $7,436,000 | 2.29% |
S. MUOIO & CO. LLC | 160,000 | $2,810,000 | 2.16% |
Omni Partners US LLC | 2,366,824 | $41,561,000 | 2.13% |